Gastric cancer: Worldwide burden and prevention opportunities

Chinese Journal of Digestive Diseases

Volumn 6, Issue 3, 2005, Pages 107-109

  Winawer, Sidney J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; DEVELOPING COUNTRY; HUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; STOMACH CANCER;

FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; STOMACH NEOPLASMS;

EID: 28944449419     PISSN: 14439611     EISSN: 14439573     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2005.00211.x     Document Type: Review

References (14)

1. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: Cancer Incidence, Mortality, and Prevalence Worldwide. Version 1.0 IARC Cancer Base No. 5. Lyon: IARC Press, 2000.
2. Zivny J, Wang TC, Yantiss R, Kim KH, Houghton J. Role of therapy or monitoring in preventing progression to gastric cancer. J Clin Gastroenterol 2003; 36: S50-60.
3. Zhang Z-F, Kurtz RC, Sun M et al. Adenocarcinomas of the esophagus and gastric cardia: medical conditions, tobacco, alcohol, socioeconomic factors. Cancer Epidemiol Biomarkers Prev 1996; 5: 761-8.
4. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004; 99: 582-8.
5. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
6. Wong C-Y, Lam SK, Wong WM et al. Helicobacter pylori eradication to prevent gastric cancer in high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-94.
7. Lara LF, Cisneros G, Gurney M et al. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection. Arch Intern Med 2003; 163: 2079-84.
8. Zhou L, Sung JJ, Lin S et al. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication. Chin Med J 2003; 116: 11-14.
9. Xia HH, Wong BC, Lam SK. Chemoprevention of gastric cancer: Current status. Chin Med J 2003; 116: 6-10.
10. Davies R, Crabbe D, Roderick P et al. A simulation to evaluate screening for Helicobacter pylori infection in the prevention of peptic ulcers and gastric cancers. Health Care Manag Sci 2002; 5: 249-58.
11. Hunt RH, Fallone C, Veldhuyzen van ZS, Sherman P, Smaill F, Thomson AB. Risks and benefits of Helicobacter pylori eradication: Current status. Can J Gastroenterol 2002; 16: 57-62.
12. Kikuchi S. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 2002; 5: 6-15.
13. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2004; 21: 32-8.
14. Winawer SJ, Classen M, Rozen P. International Digestive Disease Alliance Meeting. Digestive Disease Week, 2004, World Gastroenterology News 2004; 9: 36-7.